Skip to content
Psilocybin Research

Psilocybin and the law: the questions people actually ask

Twenty answers, checked against statutes rather than other trackers. Including the two that people most often get wrong, and act on.

Legal questionsReviewed

Not legal advice · corrections welcomed at /contact

The short answer

As of 30 August 2026, psilocybin remains a Schedule I controlled substance under the federal Controlled Substances Act. It has not been approved by the FDA and has not been rescheduled by the DEA. Under state law, Oregon and Colorado run licensed supervised-access programs that an adult aged 21 or over can use without a diagnosis, a prescription or state residency. Everywhere else, the only lawful route is an authorized clinical trial. A city that has deprioritized enforcement has not decriminalized anything, and a state trigger law creates no access until the FDA approves a psilocybin medicine and the DEA reschedules it.

This is a publication rather than a provider, and nothing here is legal advice — see our editorial standards.

Federal status
Schedule I
FDA-approved
No
States with legal access
Trigger laws awaiting FDA
4

Legal status

Is it legal, and where

The federal answer and the state answer are different answers, and confusing them is how people get hurt.

Is psilocybin legal in the United States?

No. Psilocybin remains a Schedule I controlled substance under the federal Controlled Substances Act as of 30 August 2026. It has not been approved by the FDA and has not been rescheduled by the DEA. Two states, Oregon and Colorado, run legal supervised-access programs under their own law, and an adult aged 21 or over can take psilocybin lawfully at a licensed site in either. That removes the state charge in those two states. It does not remove federal exposure, which applies everywhere in the country regardless of state law.

State-by-state trackerFederal policy in 2026

Which states have legal psilocybin?

Oregon and Colorado. They are the only 2 states where an adult aged 21 or over can lawfully take psilocybin at a licensed site with a trained facilitator. New Mexico has passed a medical psilocybin law and began accepting producer applications on 17 August 2026, but no patient can be treated there yet. 7 more states fund research or a pilot as the only lawful route, 7 have cities that deprioritized enforcement without changing state law, and in 34 psilocybin is simply illegal.

OregonColoradoNew Mexico

If my state has changed its law, why is psilocybin still illegal?

Because state law and federal law run in parallel rather than in sequence. A state can repeal its own criminal penalty, license service centers and instruct its own police, but it cannot repeal the federal Controlled Substances Act, and no state program is a defense to a federal charge. This is the same structure that has governed state cannabis programs for over a decade. We cannot tell you how likely a federal prosecution is for a person attending a licensed Oregon or Colorado session; we can tell you plainly that the legal exposure has not been removed, and that anyone describing state legalization as full legal protection is misinforming you.

What 2026 actually changed federally

Will psilocybin be legalized nationally?

Nobody can tell you that, and anyone giving you a date is guessing. The realistic route is not legalization but approval and rescheduling: the FDA approves a specific psilocybin medicine for a specific condition, and the DEA then moves that formulation out of Schedule I. Two Phase 3 trials of synthetic psilocybin met their primary endpoints in 2025 and 2026, an executive order in April 2026 directed federal agencies to accelerate psychedelic research and review, and a federal report in August 2026 told states to start planning for approval. None of those changed the schedule. If approval comes, it would cover a prescription medicine used under supervision — not recreational possession, and not mushrooms.

The 2026 federal timeline

Is psilocybin FDA-approved?

No. No psilocybin product has been approved by the FDA for any condition as of August 2026. One sponsor, Compass Pathways, has a rolling new drug application under review and holds a priority voucher that compresses the administrative review clock from roughly ten to twelve months to one or two. A voucher shortens the timetable; it does not lower the evidentiary bar for safety or efficacy, and a faster review is not an approval. The absence of approval is also why no US insurer, Medicare or Medicaid program pays for psilocybin therapy — an unapproved treatment cannot be billed.

What psilocybin therapy costs

Decriminalization

Decriminalization, and what it is not

Three words get used interchangeably in headlines and mean three different things in a courtroom.

What is the difference between decriminalization and legalization?

Decriminalization reduces or removes criminal penalties for conduct that remains prohibited. Legalization creates an affirmatively lawful route — a thing you are permitted to do. What most US cities have actually done is narrower than either: deprioritization, which instructs police to treat enforcement as their lowest priority while leaving the statute untouched. Oregon and Colorado are the only states with genuine legal access, through licensed supervised sessions; Colorado went further and made personal possession, cultivation and sharing without payment lawful for adults 21 and over. No state has decriminalized psilocybin possession across the board.

What the five categories mean

Does living in a decriminalized city protect me from arrest?

No, and this is the most consequential misunderstanding in the subject. Roughly two dozen US cities have passed measures making enforcement against entheogenic plants and fungi the lowest police priority. None of them changed a statute. Possession remains a criminal offense in every one of those cities, prosecutors keep their discretion to charge, county, state and federal agencies are not bound by a city council resolution, and the resolution itself can be repealed by the next council. Washington DC's Initiative 81 passed with 76 per cent of the vote and decriminalized nothing. If you are relying on a local measure as legal cover, you do not have legal cover.

Which cities, and what they actually did

What is a psilocybin trigger law?

A trigger law is a state statute already on the books that changes psilocybin's state status automatically once two specific federal events occur: the FDA approves a psilocybin medicine, and the DEA reschedules it. 4 states have versions — Arizona, Georgia, South Dakota and Virginia. Neither federal event has happened, so as of August 2026 these laws create no access whatsoever. A reader in Virginia who has seen the headline "Virginia legalizes psilocybin" is reading about a law that currently authorizes nothing at all, and will authorize a prescription medicine rather than general possession if it ever activates.

ArizonaVirginiaSouth Dakota

Which states are wrongly reported as decriminalized?

Three, consistently. Nevada is not decriminalized: SB 242 was amended before passage in 2023 to create a working group and nothing more, and the quantity language quoted in several national trackers comes from the introduced bill rather than the enacted law. Connecticut is not decriminalized: decriminalization bills passed the House in 2023 and 2025 and died in the Senate both times, and Connecticut's real reform is a therapy pilot. Rhode Island is not decriminalized: the 2023 bill passed one chamber and the 2026 successor was withdrawn. Acting on any of those three as though possession were decriminalized is a criminal risk.

NevadaConnecticutRhode Island

Access

Getting access, lawfully

What the two working programs require, what a trial requires, and what a retreat abroad does not change.

Can I travel to Oregon or Colorado for a psilocybin session?

Yes. Neither program has a residency requirement, and people do travel from other states for sessions. Book with a licensed service center or healing center — the state agencies publish the license registers — and budget for two days rather than an afternoon, because a session runs six to eight hours and is wrapped in preparation and integration appointments. Travel, accommodation and time off work are real costs that sit on top of the session fee, and none of it is covered by insurance.

Oregon's programColorado's programWhat it costs

Do I need a diagnosis, a prescription or state residency?

Not in Oregon or Colorado. Both programs are open to adults aged 21 and over without a diagnosis, a prescription, a referral or residency in the state — that is the design, and it is what makes them supervised-access programs rather than medical ones. You will still be screened before a session, and a legitimate provider will decline clients for whom psilocybin is contraindicated. New Mexico's program is the exception in development: it is a medical psilocybin program with qualifying conditions, and no patient can be treated there yet.

OregonNew Mexico

Can I take psilocybin home with me afterwards?

No. In Oregon, psilocybin may only be consumed at a licensed service center, and possessing it outside the program remains a criminal offense. Colorado is different in one respect — adults 21 and over may lawfully possess and grow for personal use under state law — but that permission stops at the state line. Carrying psilocybin across a state border is a federal offense regardless of where you obtained it or where you are going, and posting it is worse rather than safer. Nothing in either program creates a lawful supply to take away.

Check your own state first

Is joining a clinical trial legal in my state?

Yes. Enrolling in an authorized clinical trial is lawful in every state, costs nothing, and often compensates participants — the sponsor covers the study drug, the sessions and usually travel. It is the only lawful psilocybin route in most of the country, and 7 states have made funded research their explicit route rather than public access. The barrier is eligibility, not money. Most psilocybin trials have required participants to be off antidepressants before dosing; the 2023 JAMA trial required discontinuation for at least two weeks or five half-lives, whichever was longer, which excludes a large share of the people most interested in enrolling.

Why a trial is the cheapest routeStates funding research

What about a psilocybin retreat abroad?

We do not track foreign law and we do not vet retreat operators, so we will not tell you that a particular country or program is lawful or safe. Two things hold regardless of where a retreat is. Attending one abroad does not change your position under US law. And bringing psilocybin back into the United States is a federal offense carrying consequences well beyond a possession charge. Retreat marketing is also where the evidence is stretched hardest — the operator's incentive is to make both the law and the research sound simpler than they are, and screening standards vary enormously.

Advertising & affiliate disclosureWhat the evidence supports

There is no legal route in my state and I cannot travel. What are my options?

Then there is no lawful psilocybin option for you this year, and we would rather say that plainly than sell you a workaround. What remains available is a clinical trial, if you are eligible and can reach a site, and the treatments that are FDA-authorized and therefore billable to insurance — esketamine and transcranial magnetic stimulation are the usual comparisons for treatment-resistant depression. Neither is psilocybin. Both are lawful in every state and covered by many plans, and that difference in regulatory status, not effectiveness, is why one costs a copay and the other costs thousands.

Compare the alternativesYour state's page

Risks and records

Risks, records and practicalities

The questions people ask quietly: who should not take this, and what it costs you if it goes wrong.

Who should not take psilocybin?

Psilocybin has genuine contraindications, and the field discusses them less than it should. Lithium is one: naturalistic psilocybin use alongside lithium is associated with seizures. MAOIs are another. Antipsychotics will block the experience entirely. A personal or family history of psychosis or bipolar I disorder is an exclusion criterion in essentially every clinical trial, for good reason. Psilocybin also raises heart rate and blood pressure, so cardiac conditions and uncontrolled hypertension are screened for. This list is not exhaustive and is not a substitute for a clinical screening — any legitimate provider will screen you thoroughly, and one that does not is telling you something about itself.

The risks side of the ledger

What happens if I am arrested for psilocybin possession?

That depends on the state, the quantity and the circumstances, which is why we publish a page per state rather than one national answer. The range is genuinely wide: Michigan treats simple possession as a misdemeanor, Texas charges it as a felony under Penalty Group 2, and Wyoming's felony threshold sits at three grams of powdered material. Federal charges are possible anywhere, including in Oregon and Colorado. Nothing we publish is legal advice. If you are facing a charge, speak to a lawyer licensed in your state before you speak to anyone else.

Penalties by state

Does psilocybin show up on a drug test?

Not on standard panels. The routine workplace and pre-employment tests used in the United States screen for a fixed short list of substances, and psilocybin is not on it. Assays that detect psilocin do exist and can be ordered specifically, which is what matters if you are tested by a court, a licensing board or a safety-sensitive employer rather than by a standard hiring process. We do not publish detection windows: they vary with the assay, the dose and the individual, and a confident number from a website is not something to plan your life around.

Can I lose my job or a professional license over psilocybin?

Possibly, and legal access in Oregon or Colorado does not settle it. A state program makes the conduct lawful under that state's law. It does not create an employment protection, and it does not bind a professional licensing board, a federal employer, or a role governed by federal drug-testing rules. Clinicians, pilots, commercial drivers and anyone holding a federal clearance are subject to regimes that sit outside state drug law entirely. We cannot tell you how a particular board or employer will treat a disclosed session; an employment lawyer in your state can, and that conversation is worth having before the session rather than after it.

Is it legal to grow mushrooms, or to buy spores?

These are two different questions with two different answers. Cultivation is lawful for adults aged 21 and over in Colorado for personal use under Proposition 122, and illegal everywhere else — it is a separate offense from possession rather than a lesser version of it. Spores are treated differently again: because spores do not themselves contain psilocybin, some states handle them separately from the mushroom, and the resulting patchwork is genuinely inconsistent from state to state. Some prohibit them explicitly, others do not address them, and the absence of an explicit prohibition is not the same as permission. We do not give sourcing advice and we do not link to vendors. Check your state's page, and if the answer matters legally, ask a lawyer rather than a forum.

ColoradoYour state's page

Next

Answer it for your own state

A national answer is only ever half of one. The statute that decides your position is your state's.

References

  1. 1.Oregon Health Authority. Oregon Psilocybin Services.
  2. 2.Colorado Department of Revenue, Natural Medicine Division.
  3. 3.New Mexico Department of Health. Medical Psilocybin Program.
  4. 4.Nayak SM, et al. Naturalistic psilocybin use with lithium is associated with seizures. Pharmacopsychiatry. 2021;54(5):240–45.Survey-based, but the signal is strong and the outcome severe. Lithium is a genuine contraindication.
  5. 5.Raison CL, et al. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA. 2023;330(9):843–53.Required antidepressant discontinuation for ≥2 weeks or 5 half-lives before dosing.
  6. 6.Lewis G, et al. Maintenance or Discontinuation of Antidepressants in Primary Care (ANTLER). N Engl J Med. 2021;385:1257–67.56% relapsed within a year after discontinuation vs 39% on maintenance. The reason no website should tell you to stop your medication.
  7. 7.SAMHSA report advising states to prepare for FDA approval of psychedelic therapies. August 2026.Coverage of the federal report. Guidance to states; changes no one's legal position.

This is not legal advice. Drug law changes quickly, applies differently depending on quantity and circumstance, and federal law applies everywhere regardless of state status. If you are facing a charge, talk to a lawyer licensed in your state. State dataset last reviewed August 30, 2026; these answers last reviewed August 31, 2026.